Cargando…
SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)
Most muscle-invasive bladder cancer (BC) are urothelial carcinomas (UC) of transitional origin, although histological variants of UC have been recognized. Smoking is the most important risk factor in developed countries, and the basis for prevention. UC harbors high number of genomic aberrations tha...
Autores principales: | Valderrama, Begoña P., González-del-Alba, Aránzazu, Morales-Barrera, Rafael, Peláez Fernández, Ignacio, Vázquez, Sergio, Caballero Díaz, Cristina, Domènech, Montserrat, Fernández Calvo, Ovidio, Gómez de Liaño Lista, Alfonso, Arranz Arija, José Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986688/ https://www.ncbi.nlm.nih.gov/pubmed/35347572 http://dx.doi.org/10.1007/s12094-022-02815-w |
Ejemplares similares
-
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
por: Méndez-Vidal, María José, et al.
Publicado: (2023) -
SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
por: Rueda Domínguez, Antonio, et al.
Publicado: (2022) -
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)
por: González del Alba, A., et al.
Publicado: (2018) -
SEOM—GECOD clinical guideline for unknown primary cancer (2021)
por: Losa, Ferrán, et al.
Publicado: (2022) -
SEOM-GEICO clinical guidelines on endometrial cancer (2021)
por: Barretina-Ginesta, María Pilar, et al.
Publicado: (2022)